• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18F-FDG PET/CT 显像表现为遗传性平滑肌瘤病和肾细胞癌综合征合并肾上腺皮质癌

Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome Combined With Adrenocortical Carcinoma on 18F-FDG PET/CT.

机构信息

From the Department of Nuclear Medicine & Minnan PET Center, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, Xiamen, China.

出版信息

Clin Nucl Med. 2017 Sep;42(9):692-694. doi: 10.1097/RLU.0000000000001760.

DOI:10.1097/RLU.0000000000001760
PMID:28737576
Abstract

Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome is a recognized distinct phenotypic variant of multiple cutaneous and uterine leiomyomatosis. The present case reports an extremely rare case of HLRCC syndrome combined with adrenocortical carcinoma. The case suggests that HLRCC should be considered in any young patient with bulky uterine leiomyomas and renal cell cancer, and F-FDG PET/CT can help detect unexpected additional primary malignancy in a patient with known cancer.

摘要

遗传性平滑肌瘤病和肾细胞癌(HLRCC)综合征是一种公认的多发性皮肤和子宫平滑肌瘤病的独特表型变异。本病例报告了一例极为罕见的 HLRCC 综合征合并肾上腺皮质癌。该病例提示,对于有大的子宫平滑肌瘤和肾细胞癌的年轻患者,应考虑 HLRCC,而 F-FDG PET/CT 可帮助检测已知癌症患者中意外的其他原发性恶性肿瘤。

相似文献

1
Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome Combined With Adrenocortical Carcinoma on 18F-FDG PET/CT.18F-FDG PET/CT 显像表现为遗传性平滑肌瘤病和肾细胞癌综合征合并肾上腺皮质癌
Clin Nucl Med. 2017 Sep;42(9):692-694. doi: 10.1097/RLU.0000000000001760.
2
Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome-Associated Renal Cell Carcinoma Showing High FDG Uptake.遗传性平滑肌瘤病和肾细胞癌综合征相关肾细胞癌表现为高 FDG 摄取。
Clin Nucl Med. 2019 May;44(5):420-423. doi: 10.1097/RLU.0000000000002495.
3
Hereditary leiomyomatosis and renal cell cancer (HLRCC): cutaneous and renal manifestations requiring a multidisciplinary team approach.遗传性平滑肌瘤病和肾细胞癌(HLRCC):皮肤和肾脏表现需要多学科团队协作处理。
BMJ Case Rep. 2017 Apr 11;2017:bcr-2016-215115. doi: 10.1136/bcr-2016-215115.
4
Expanding morphological and clinical aspects of hereditary leiomyomatosis and renal cell carcinoma (HLRCC): a case report in a patient with unusual morphology and clinical presentation.扩展遗传性平滑肌瘤病和肾细胞癌(HLRCC)的形态学和临床方面:一例具有不寻常形态和临床表现的患者的病例报告。
Virchows Arch. 2018 Dec;473(6):775-779. doi: 10.1007/s00428-018-2420-3. Epub 2018 Aug 31.
5
[Acute caesarian section due to renal tumour with spontaneously emerged perirenal haematoma].[因肾肿瘤伴自发性肾周血肿而行急诊剖宫产术]
Ugeskr Laeger. 2017 Apr 24;179(17).
6
Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC): Report of a Family Pedigree.遗传性平滑肌瘤病和肾细胞癌(HLRCC):家族谱系报告。
Am J Med Sci. 2020 Dec;360(6):724-727. doi: 10.1016/j.amjms.2020.05.048. Epub 2020 Jun 3.
7
Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case report.遗传性平滑肌瘤病和肾细胞癌(HLRCC)相关肾细胞癌对纳武利尤单抗和伊匹单抗联合免疫治疗的完全缓解:病例报告。
Fam Cancer. 2021 Jan;20(1):75-80. doi: 10.1007/s10689-020-00195-0. Epub 2020 Jul 15.
8
Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer.遗传性平滑肌瘤病和肾癌中的肾上腺结节性增生。
J Urol. 2013 Feb;189(2):430-5. doi: 10.1016/j.juro.2012.07.139. Epub 2012 Sep 19.
9
MR Spectroscopy for Detecting Fumarate Hydratase Deficiency in Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome.磁共振波谱分析在遗传性平滑肌瘤病和肾细胞癌综合征中检测延胡索酸水合酶缺陷
Radiology. 2022 Dec;305(3):631-639. doi: 10.1148/radiol.212984. Epub 2022 Aug 9.
10
Hereditary leiomyomatosis and renal cell cancer syndrome: An update and review.遗传性平滑肌瘤病和肾细胞癌综合征:更新与综述。
J Am Acad Dermatol. 2017 Jul;77(1):149-158. doi: 10.1016/j.jaad.2017.01.023. Epub 2017 Mar 14.

引用本文的文献

1
Diagnosis of Hereditary Leiomyomatosis and Renal Cell Cancer After Subcapsular Renal Hematoma.肾包膜下血肿后遗传性平滑肌瘤病和肾细胞癌的诊断
IJU Case Rep. 2025 Feb 20;8(3):218-222. doi: 10.1002/iju5.70009. eCollection 2025 May.
2
Metabolic tumor parameters on F-FDG PET/CT can predict the expression of PD-L1 and prognosis in patients with fumarate hydratase-deficient renal cell carcinoma.F-FDG PET/CT上的代谢肿瘤参数可预测延胡索酸水合酶缺陷型肾细胞癌患者的PD-L1表达及预后。
Ann Nucl Med. 2025 Mar 15. doi: 10.1007/s12149-025-02039-2.
3
A Case of Metastatic Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome-Associated Renal Cell Carcinoma Treated with a Sequence of Axitinib and Nivolumab Following Cytoreductive Nephrectomy.
1例转移性遗传性平滑肌瘤病和肾细胞癌综合征相关肾细胞癌在减瘤性肾切除术后序贯使用阿昔替尼和纳武单抗治疗的病例
J Kidney Cancer VHL. 2020 Jul 20;7(2):6-10. doi: 10.15586/jkcvhl.2020.148. eCollection 2020.